The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, S.
Right arrow Articles by Kaplan, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, S.
Right arrow Articles by Kaplan, M. H.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2000, 165: 10-14.
Copyright © 2000 by The American Association of Immunologists

CUTTING EDGE

Cutting Edge: Differential Expression of Chemokines in Th1 and Th2 Cells Is Dependent on Stat6 But Not Stat41

Shangming Zhang*, Nicholas W. Lukacs{dagger}, Victoria A. Lawless*, Steven L. Kunkel{dagger} and Mark H. Kaplan2,*

* Department of Microbiology and Immunology, Walther Oncology Center, Indiana University School of Medicine, and Walther Cancer Institute, Indianapolis, IN 46208; and {dagger} Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results and Discussion
 References
 
The in vivo function of Th cell subsets is largely dependent on the ability of differentiated CD4+ T cells to be recruited to specific sites and secrete restricted sets of cytokines. In this paper we demonstrate that Th1 and Th2 cells secrete discrete patterns of chemokines, small m.w. cytokines that function as chemoattractants in inflammatory reactions. Th2 cells secrete macrophage-derived chemokine and T cell activation gene 3, and acquisition of this pattern of expression is dependent on Stat6. In contrast, Th1 cells secrete lymphotactin and RANTES, though unlike IFN-{gamma}, expression of these chemokines is independent of Stat4. We further show that supernatants from activated Th2 cells preferentially induce the chemotaxis of Th2 over Th1 cells, corresponding with Stat6-dependent expression of CCR4 and CCR8 in Th2 cells. These data provide the basis for restricted and direct T cell-mediated cellular recruitment to sites of inflammation.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results and Discussion
 References
 
Differentiated CD4+ Th cells can be divided into Th1 and Th2 subsets based on their cytokine production following Ag stimulation (1, 2). Th1 cells produce IFN-{gamma} and mediate delayed-type hypersensitivity and protection against intracellular pathogens. The Th2 subset produces IL-4, IL-5, IL-10, and IL-13 and is implicated in humoral and allergic responses. The differentiation of these Th subsets is dependent on cytokine-stimulated genetic programs. IL-12-activated Stat4 is required for the development of fully functional Th1 cells (3, 4, 5). Similarly, IL-4-activated Stat6 is essential for the differentiation of Th2 cells (6, 7, 8).

Although the exact nature of the STAT protein activated genetic program is unknown, it has been demonstrated that genes other than cytokines are differentially expressed between Th1 and Th2 cells. Several of these are chemokine receptors including CXCR3, CCR5, and CCR7, preferentially expressed in Th1 cells (9, 10, 11), and CCR3, CCR4, and CCR8, which are preferentially expressed in Th2 cells (9, 10, 12, 13). This provides a mechanism by which Th subsets can be selectively recruited to sites of inflammation. Indeed, Th1 cells selectively undergo chemotaxis to IFN-{gamma}-inducible protein (IP-10), a ligand for CXCR3, and RANTES, macrophage inflammatory protein 1{alpha} (MIP-1{alpha})3 and MIP-1ß, ligands for CCR5 (9, 14). Similarly, Th2 cells selectively undergo chemotaxis to macrophage-derived chemokine (MDC), T cell activation gene 3 (TCA3), and thymus- and activation-regulated chemokine (TARC), chemokines that are ligands for CCR4 and CCR8 (9, 13, 15, 16, 17).

Because Th subsets are important in regulating inflammatory processes, it seemed likely that they would also secrete discrete patterns of chemokines to recruit restricted types of cells to sites of inflammation. Although chemokine receptor expression in Th subsets has been extensively described, restricted expression of chemokines between Th subsets has not been carefully examined. We have determined the expression patterns of 18 chemokines and shown that there is restricted expression of chemokines between Th1 and Th2 cells that is dependent on the function of Stat6 but not Stat4. We further demonstrate that Th2 supernatants preferentially recruit Th2 rather than Th1 cells.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results and Discussion
 References
 
Mice

The generation of Stat4- and Stat6-deficient mice has been previously described (3, 6). Both strains have been backcrossed 10 generations to the BALB/c genetic background and were bred as homozygotes in the Indiana University Laboratory Animal Resource Center. Wild-type BALB/c mice were purchased from Harlan Bioproducts (Indianapolis, IN).

T cell differentiation

Total spleen cells were depleted of CD8+, B220+, and FcR+ cells. CD4+ cells were positively selected from the resulting populations using magnetic beads from Miltenyi Biotec (Auburn, CA) according to the manufacturer’s instructions. Final CD4+ populations were >97% CD4+ as determined by FACS analysis. CD4+ T cells cultured at 106 cells/ml were then differentiated with 2 µg/ml plate-bound anti-CD3 (145-2C11) plus 1 µg/ml anti-CD28 (PharMingen, San Diego CA) to Th1 (1 ng/ml IL-12 (Peprotech, Rocky Hill, NJ) and 10 µg/ml anti-IL-4 (11B11)) or Th2 (10 ng/ml IL-4 (Peprotech) plus 10 µg/ml anti-IFN-{gamma} (R4/6A2)) populations. After 6 days, cells were restimulated with 2 µg/ml plate-bound anti-CD3 for the indicated times for RNA analysis or for 24 h to recover supernatants.

Chemokine mRNA analysis

Total RNA samples were isolated from cell populations indicated using Trizol (Life Technologies/BRL, Bethesda, MD). RNase protection assays (RPA) were done according to the manufacturer’s instructions (PharMingen). cDNA probes for monokine induced by IFN-{gamma} (MIG), TARC, and CCR8 were generated by PCR, subcloned, and sequenced to confirm the identity of the probes. The cDNA probes for MDC (a gift of Dr. Uli Schindler, Tularik, South San Francisco, CA), Breast And Kidney, Exodus-1, -2 and -3 (gifts of Dr. Rob Hromas, Indiana University, Indianapolis, IN), and CCR4 (a gift of Dr. Byung Youn, Indiana University, Indianapolis, IN), and PCR probes were labeled using random decamers (Ambion, Austin, TX) and hybridized overnight in a formamide hybridization buffer.

ELISAs

ELISAs for IL-4 and IFN-{gamma} were performed as described previously (5, 6). Rabbit anti-murine MDC Abs were prepared by multiple-site immunization of New Zealand White rabbits with recombinant murine MDC (R&D Systems, Rochester, MN) in CFA. Polyclonal Abs were titered by direct ELISA and specifically verified by the failure to cross-react to other chemokines. The IgG portion of the serum was purified over a protein A column and used in a sandwich ELISA. Goat anti-murine RANTES was made as previously described (18). The levels of chemokines in cell-free supernatants were measured by specific ELISA using a modification of a double-ligand method as previously described (19).

Chemotaxis assay

Chemotaxis assays were performed in a Costar (Cambridge, MA) Transwell with a 3-µm pore filter. Assays were performed in chemotaxis buffer (RPMI 1640, 1% BSA, and 20 mM HEPES). Supernatants from the indicated Th population were diluted 1:2 with chemotaxis buffer in the lower chamber and 5 x 105 Th2 cells in the upper chamber. After 4 h, cells in the lower chamber were counted using trypan blue exclusion. Rabbit anti-MDC serum was purified using protein G and used in the assay at 10 µg/ml. Anti-TCA3 was purchased from PharMingen. Control Ig was purified by protein G from normal rabbit serum. Supernatants were incubated with anti-MDC for 1 h on ice before adding to Transwell culture.


   Results and Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
References
 
Differential expression of chemokines in Th1 and Th2 cells

Because chemokines are known to recruit cells to sites of inflammation, and because Th subsets mediate distinct types of inflammation, we examined whether Th1 and Th2 cells secreted distinct sets of chemokines. CD4+ T cells (>97% pure), purified from wild-type spleen cells, were differentiated to Th1 or Th2 phenotypes. After 1 wk in culture, cells were restimulated with anti-CD3. Restimulation of Th1 and Th2 cultures resulted in secretion of IFN-{gamma} and IL-4, respectively (Fig. 1GoA). RPA were used to assess the expression of a panel of chemokines in cultures that were unstimulated or activated for the time periods indicated with anti-CD3. Expression of RANTES and lymphotactin was induced by anti-CD3 specifically in Th1 populations (Fig. 1GoB). By contrast, Th2 cells selectively expressed TCA3 following stimulation with anti-CD3. To determine whether expression of these chemokines in Th subsets was dependent on the genetic programs activated by Stat4 and Stat6, we performed the differentiation described above with CD4+ T cells from mice deficient in either Stat4 or Stat6. These cultures secreted cytokines as predicted from previous results (Fig. 1GoA). TCA3 expression was dependent on Stat6, as Stat6-deficient CD4+ Th2 cultures did not express TCA3 (Fig. 1GoB). Surprisingly, and in contrast to IFN-{gamma}, RANTES and lymphotactin were expressed in Stat4-deficient Th1 cultures (Fig. 1GoB). This suggests that Stat4 is not required for RANTES and lymphotactin expression in Th1 populations and also correlates with the ability of Stat4-deficient lymphocytes to mediate reduced but significant tissue inflammation (5).



View larger version (71K):
[in this window]
[in a new window]
  		FIGURE 1. Expression of chemokines in Th1 and Th2 populations. A, ELISA of IFN-{gamma} and IL-4 expression in differentiated CD4+ cells. CD4+ cells were purified from wild-type, Stat4-deficient, and Stat6-deficient spleens and differentiated to Th1 or Th2 populations as indicated. After 6 days in culture, T cells were restimulated with anti-CD3 for 24 h and supernatants were recovered for analysis by ELISA. B, RPA of RNA from differentiated CD4+ cells. CD4+ cells, differentiated as in A, were activated with anti-CD3 and RNA was isolated at the indicated times. The protection assay was performed with the mCK-5 templates (PharMingen). Labels on the left indicate the probe for each chemokine. Labels on the right indicate the protected fragment following RNase digestion. The results are representative of five experiments.

 
We also tested the differential expression of several other chemokines by Northern blot analysis. Th cells were differentiated as above and RNA was isolated at the time points indicated following stimulation with anti-CD3. Of the chemokines tested, MDC (also known as STCP-1 and ABCD-1) was inducibly expressed specifically in Th2 cells and not in Th1 cells (Fig. 2GoA). Because IL-4 induces, and IFN-{gamma} represses, MDC expression from macrophages, dendritic cells and B cells (16, 20, 21) we tested whether anti-CD3 induced cytokines were responsible for Th2-restricted MDC expression. Wild-type Th2 cells restimulated with anti-CD3 in the presence of anti-IL-4 showed that the absence of IL-4 reduced but did not abrogate MDC expression (Fig. 2GoB). Thus it is likely that both the anti-CD3 and IL-4 signals contribute to MDC expression in Th2 cells. Th1 cells stimulated with anti-CD3 expressed barely detectable levels of MDC and even in the presence of neutralizing anti-IFN-{gamma} were not inducible by IL-4 (Fig. 2GoB). The restricted expression of MDC was also dependent on Stat6, because Stat6-deficient Th2 cultures did not express MDC even when supplemented with IL-4 (Fig. 2GoB).



View larger version (61K):
[in this window]
[in a new window]
  		FIGURE 2. Expression of MDC in Th1 and Th2 populations. A, Northern blot analysis of MDC expression. CD4+ T cells were differentiated and restimulated with anti-CD3 for the time periods indicated as in Fig. 1Go. RNA was isolated, run on formaldehyde agarose gels, transferred to nylon membrane, and probed with a MDC cDNA. Filters were stripped and reprobed with a TCR{alpha} probe as a loading control. B, Wild-type or Stat6-deficient T cells were differentiated as in A and were left unstimulated or stimulated with anti-CD3 for 24 h in the presence or absence of 10 µg/ml anti-IFN-{gamma}, 1 or 10 µg/ml anti-IL-4, or 10 ng/ml IL-4 as indicated. Northern blot analysis was performed as in A. The results shown are representative of four experiments for A and two experiments for B.

 
To demonstrate that the differentially expressed chemokines were indeed being secreted, we also performed ELISAs on supernatants from Th1, Th2, Stat4-deficient Th1, and Stat6-deficient Th2 cultures stimulated for 24 h with anti-CD3. Secretion of RANTES and MDC was detectable in supernatants (Fig. 3Go) with a similar restricted pattern of expression as seen in RPA and Northern blot analysis (Figs. 1Go and 2Go).



View larger version (12K):
[in this window]
[in a new window]
  		FIGURE 3. Secretion of RANTES and MDC by Th1 and Th2 populations. CD4+ T cells of the indicated genotypes were differentiated and restimulated with anti-CD3 for 24 h as in Fig. 1GoA. Supernatants were recovered and tested by ELISA for levels of RANTES and MDC. Results are representative of three experiments.

 
Common expression of chemokines in Th1 and Th2 cells

MIP-1{alpha} and MIP-1ß are often associated with Th1-mediated inflammatory lesions (22, 23, 24). However, our RPA analysis demonstrated that Th1 cells express only about 2-fold more RNA for these chemokines than Th2 cells. Importantly, expression of both MIP-1{alpha} and MIP-1ß was readily detectable in Th2 cells (Fig. 1GoB). This difference was also reflected in ELISAs where MIP-1{alpha} was readily detectable in supernatants of Th2 cells, but accumulated in Th1 supernatants at 2- to 5-fold higher levels than in Th2 supernatants (data not shown). Furthermore, the absence of either Stat4 or Stat6 had only minor affects on the expression of MIP-1{alpha} and MIP-1ß (Fig. 1GoB) or the secretion of MIP-1{alpha} (data not shown).

Other chemokines had undetectable expression in either Th1 or Th2 cells. These included chemokines that were analyzed by RPA in Fig. 1GoB (eotaxin, monocyte chemoattractant protein-1 (MCP-1), MIP-2, and IFN-{gamma}-inducible protein (IP-10)), Northern blot analysis (MIG, TARC, Exodus-1 (LARC/MIP-3{alpha}), Exodus-2 (TCA4/SLC/6Ckine), Exodus-3 (ELC/MIP-3ß/CKß11) and BRAK; data not shown), and ELISA (C10 and MCP-3; data not shown).

Th2 supernatants preferentially recruit Th2 cells

The chemokines that are preferentially expressed in Th2 cells are also ligands for receptors that are differentially expressed between Th subsets. The Th2 chemokines MDC and TCA3 signal through CCR4 and CCR8, respectively, which are also expressed at greater levels in Th2 cells than in Th1 cells and are expressed in a Stat6-dependent manner (Fig. 4GoA). This led us to the prediction that Th2-generated chemokines would be more effective at stimulating the chemotaxis of Th2 cells. To test this, we used Th2 supernatants generated as above, in a standard, two-chamber migration assay. As shown in Fig. 4GoB, Th2 supernatants were significantly more effective in stimulating chemotaxis in Th2 cells than were Th1 supernatants or media alone (p < 0.01). Th2-induced chemotaxis could be inhibited by coincubation of the supernatant with anti-MDC, demonstrating that Th2-derived MDC is an important mediator of Th2 chemoattraction. Incubation with anti-TCA3 did not significantly affect Th2 migration in response to Th2 supernatants. Thus, Th2-derived chemokines can differentially recruit Th subsets.



View larger version (37K):
[in this window]
[in a new window]
  		FIGURE 4. Chemotaxis of Th2 cells. A, CD4+ T cells of the indicated genotypes were differentiated and restimulated with anti-CD3 for the time periods indicated as in Fig. 1Go. RNA was isolated as in Fig. 2Go, and filters were sequentially hybridized with probes for CCR4, CCR8, and TCR-{alpha} as a control. B,. Supernatants from Th1 or Th2 cells were generated as in Fig. 1GoA. Th1 and Th2 cells were differentiated as in Fig. 1GoA. Th2 cells were placed in the upper chamber of a Costar Transwell with a 3-µm pore size membrane. Th1 or Th2 supernatants supplemented with Abs as indicated, or medium as control, were placed in the bottom chamber diluted 2-fold with assay medium. After 4 h, the number of cells in the bottom chamber were counted using trypan blue exclusion. The results shown are the average of ± SE of triplicate wells and are representative of three experiments.

 
This report describes the differential expression of specific CC chemokines in Th1 and Th2 subsets. The issue of differential expression of chemokines in Th subsets has been addressed in several reports with differing results. MDC expression has been observed in neither or both Th1 or Th2 populations/clones (16, 25, 26). TCA3 was expressed in transgenic Th2 cell populations but was also seen expressed in both Th1 and Th2 clones (27, 28). MIP-1{alpha}, MIP-1ß, and RANTES have also been shown to be both differentially and similarly expressed in Th1 and Th2 populations (25, 28). Some of these discrepancies may be simply explained by the use of methods that were not quantitative enough to distinguish preferential expression in Th subsets or by differences in cultured primary T cells vs long-term T cell clones. Our report describes the systematic and quantitative examination of the expression of 18 chemokines in primary, polyclonally activated, and purified CD4+ cells that have been polarized to the Th1 or Th2 phenotype.

The differential dependence on STAT proteins for the acquisition of chemokine secreting phenotypes is distinct from that required for cytokines. Although Stat6 appears to be necessary for the development of Th2 cells and secretion of IL-4, MDC, and TCA3, there is not the same requirement for Stat4. In the absence of Stat4, Th1 cells can still acquire a chemokine-secreting phenotype that includes RANTES and lymphotactin. We have previously suggested that Th1-like populations can be generated in the absence of Stat4 (5). However, this observation was complicated by the direct effects of Stat4 on IFN-{gamma} expression, which served as the sole marker for Th1 cells (3, 5). Using RANTES and lymphotactin as representative chemokines of Th1 and not Th2 cells, we provide further evidence here that cells with some characteristics of Th1 cells can develop in the absence of Stat4. Thus, the differential expression of chemokines in Th1 and Th2 cells offers additional markers for analysis of Th subsets that may be important for tracking and detecting Th cells in vivo and in vitro.

Our data also provide a novel view of the biology of Th1 and Th2 cells. In many instances Th cells have been characterized as recruits rather than recruiters to sites of inflammation. This study suggests that Th cells can contribute to inflammation not simply by secretion of cytokines such as IFN-{gamma} and IL-4, which regulate inflammatory processes, but also by secreting specific subsets of chemokines to recruit additional cells to an inflamed site. For example, both MDC and Th2 cells are required for allergic airway hypersensitivity (17, 26, 29, 30), raising the possibility that Th2 cells may be a relevant source of this chemokine during allergic inflammation. Similarly, anti-RANTES decreases migration into sites of Th1-mediated inflammation (31, 32, 33). Although lymphotactin has reproducibly been identified in Th1 cells (Refs. 28 and 34 , and this report), the lymphotactin receptor, XCR1, is expressed on CD8+ cells and equally on Th1 and Th2 cells (Ref. 35 , and our unpublished results). Thus, in Th1-regulated inflammation, lymphotactin may act primarily to recruit CD8+ cytotoxic cells to inflamed sites. These observations provide the basis for understanding specific T cell-mediated recruitment of leukocytes to sites of inflammation. They also suggest additional targets for modulating chemokine-mediated inflammation in vivo.


   Acknowledgments
 
We thank Ulrike Schindler, Byung Youn, and Rob Hromas for providing cDNA probes and Michael Grusby for providing Stat4-/- and Stat6-/- breeding pairs. We also thank Drs. Alexander Dent and Hal Broxmeyer for critical review of this manuscript.


   Footnotes
 
1 M.H.K. is a Special Fellow of the Leukemia and Lymphoma Society. This work was supported by a grant from the National Institutes of Health (AI45515) to M.H.K. Back

2 Address correspondence and reprint requests to Dr. Mark H. Kaplan, Department of Microbiology and Immunology, Walther Oncology Center, Indiana University School of Medicine, 1044 West Walnut Street, Room 302, Indianapolis, IN 46202. Back

3 Abbreviations used in this paper: MIP, macrophage inflammatory protein; MDC, macrophage-derived chemokine; TARC, thymus- and activation-regulated chemokine; MIG, monokine induced by IFN-{gamma}; RPA, RNase protection assay. Back

Received for publication March 1, 2000. Accepted for publication May 1, 2000.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 

  1. Abbas, A. K., K. M. Murphy, A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.[Medline]
  2. O’Garra, A.. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8:275.[Medline]
  3. Kaplan, M. H., Y.-L. Sun, T. Hoey, M. J. Grusby. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174.[Medline]
  4. Thierfelder, W. E., J. M. van Deursen, K. Yamamoto, R. A. Tripp, S. R. Sarawar, R. T. Carson, M. Y. Sangster, D. A. A. Vignali, P. C. Doherty, G. C. Grosveld, J. N. Ihle. 1996. Requirement for Stat4 in interleukin-12 mediated responses of natural killer and T cells. Nature 382:171.[Medline]
  5. Kaplan, M. H., A. L. Wurster, M. J. Grusby. 1998. A Stat4-independent pathway for the development of Th1 cells. J. Exp. Med. 188:1191.[Abstract/Free Full Text]
  6. Kaplan, M. H., U. Schindler, S. T. Smiley, M. J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4:313.[Medline]
  7. Shimoda, K., J. van Deursen, M. Y. Sangster, S. R. Sarawar, R. T. Carson, R. A. Tripp, C. Chu, F. W. Quelle, T. Nosaka, D. A. A. Vignali, et al 1996. Lack of IL-4 induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630.[Medline]
  8. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S.-I. Kashiwamura, K. Nakanishi, N. Yoshido, T. Kishimoto, S. Akira. 1996. Essential role of Stat6 in IL-4 signalling. Nature 380:627.[Medline]
  9. Bonecchi, R., G. Bianchi, P. P. Bordignon, D. D’Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, A. Mantovani, F. Sinigaglia. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cell (Th1s) and Th2s. J. Exp. Med. 187:129.[Abstract/Free Full Text]
  10. Sallusto, F., D. Lenig, C. R. MAckay, A. Lanzavecchia. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:875.[Abstract/Free Full Text]
  11. Randolph, D. A., G. Huang, C. J. L. Carruthers, L. E. Bromley, D. D. Chaplin. 1999. The role of CCR7 in Th1 and Th2 cell localization and delivery of B cell help in vivo. Science 286:2159.[Abstract/Free Full Text]
  12. Sallusto, F., C. R. Mackay, A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005.[Abstract/Free Full Text]
  13. Zingoni, A., H. Soto, J. A. Hedrick, A. Stoppacciaro, C. T. Storlazzi, F. Sinigaglia, D. D’Ambrosio, A. O’Garra, D. Robinson, M. Rocchi, et al 1998. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J. Immunol. 161:547.[Abstract/Free Full Text]
  14. Siveke, J. T., A. Hamann. 1998. T helper 1 and T helper 2 cells respond differentially to chemokines. J. Immunol. 160:550.[Abstract/Free Full Text]
  15. Imai, T., M. Baba, M. Nishimura, M. Kakizaki, S. Takagi, O. Yoshie. 1997. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem. 272:15036.[Abstract/Free Full Text]
  16. Andrew, D. P., M. Chang, J. McNinch, S. Wathen, M. Rihanek, J. Tseng, M. P. Spellberg, III C. G. Elias. 1998. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J. Immunol. 161:5027.[Abstract/Free Full Text]
  17. Gonzalo, J.-A., Y. Pan, C. M. Lloyd, G.-Q. Jia, G. Yu, B. Dussault, C. A. Powers, A. E. I. Proudfoot, A. J. Coyle, D. Gearing, J.-C. Gutierrez-Ramoz. 1999. Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. J. Immunol. 163:403.[Abstract/Free Full Text]
  18. Lukacs, N. W., R. M. Streiter, K. Warmington, P. Lincoln, S. W. Chensue, S. L. Kunkel. 1997. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation. J. Immunol. 158:4398.[Abstract]
  19. Lukacs, N. W., S. L. Kunkel, R. M. Streiter, K. Warmington, S. W. Shensue. 1993. The role of macrophage inflammatory protein 1{alpha} in Schistosoma mansoni egg-induced granulomatous inflammation. J. Exp. Med. 177:1551.[Abstract/Free Full Text]
  20. Bonecchi, R., S. Sozzani, J. T. Stine, W. Luini, G. D’Amico, P. Allavena, D. Chantry, A. Mantovani. 1998. Divergent effects of interleukin-4 and interferon-{gamma} on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses. Blood 92:2668.[Abstract/Free Full Text]
  21. Schaniel, C., E. Pardali, F. Sallusto, M. Speletas, C. Ruedl, T. Shimizu, T. Seidl, J. Andersson, F. Melchers, A. G. Rolink, P. Sideras. 1998. Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells. J. Exp. Med. 188:451.[Abstract/Free Full Text]
  22. Schrum, S., P. Probst, B. Fleischer, P. F. Zipfel. 1996. Synthesis of the CC-chemokines MIP-1{alpha}, MIP-1ß, and RANTES is associated with a type 1 immune response. J. Immunol. 157:3598.[Abstract]
  23. Trumpfheller, C., K. Tenner-Racz, P. Racz, B. Fleischer, S. Frosch. 1998. Expression of macrophage inflammatory protein (MIP)-1{alpha}, MIP-1ß and RANTES genes in lymph nodes from HIV+ individuals: correlation with a Th1-type cytokine response. Clin. Exp. Immunol. 112:92.[Medline]
  24. Balashov, K. E., J. B. Rottman, H. L. Weiner, W. W. Hancock. 1999. CCR5+ and CXCR3+ T cells are increased in multiple sclerosisi and their ligands MIP-1{alpha} and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. USA 96:6873.[Abstract/Free Full Text]
  25. Sallusto, F., E. Kremmer, B. Palermo, A. Hoy, P. Ponath, S. Qin, R. Forster, M. Lipp, A. Lanzavecchia. 1999. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur. J. Immunol. 29:2037.[Medline]
  26. Lloyd, C. M., T. Delaney, T. Nguyen, J. Tian, C. Martinez-A, A. J. Coyle, J.-C. Guiteirrez-Ramos. 2000. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge. J. Exp. Med. 191:265.[Abstract/Free Full Text]
  27. Wilson, S. D., P. R. Burd, P. R. Billings, C. A. Martin, M. E. Dorf. 1988. The expression and regulation of a potential lymphokine gene (TCA3) in CD4 and CD8 T cell clones. J. Immunol. 88:1563.
  28. Bradley, L. M., V. C. Asensio, L.-K. Schioetz, J. Harbertson, T. Krahl, G. Patstone, N. Woolf, I. L. Campbell, N. Sarvetnick. 1999. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J. Immunol. 162:2511.[Abstract/Free Full Text]
  29. Akimoto, T., F. Numata, M. Tamura, Y. Takata, N. Higashida, T. Takashi, K. Takeda, S. Akira. 1998. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducer and activator of transcription (STAT)6-deficient mice. J. Exp. Med. 187:1537.[Abstract/Free Full Text]
  30. Kuperman, D., B. Schofield, M. Wills-Karp, M. J. Grusby. 1998. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J. Exp. Med. 187:939.[Abstract/Free Full Text]
  31. VanOtteren, G. M., R. M. Streiter, S. L. Kunkel, III R. Paine, M. J. Greenberger, J. M. Danforth, M. D. Burdick, T. J. Standiford. 1995. Compartmentalized expression of RANTES in a murine model of endotoxemia. J. Immunol. 154:1900.[Abstract]
  32. Chensue, S. W., K. S. Warmington, E. J. Allenspach, B. Lu, C. Gerard, S. L. Kunkel, N. W. Lukacs. 1999. Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation. J. Immunol. 163:165.[Abstract/Free Full Text]
  33. Kawai, T., M. Seki, K. Hiromatsu, J. W. Eastcott, G. F. M. Watts, M. Sugai, D. J. Smith, S. A. Porcelli, M. A. Taubman. 1999. Selective diapedesis of Th1 cells induced by endothelial cell RANTES. J. Immunol. 163:3269.[Abstract/Free Full Text]
  34. Hautamaa, D., R. Merica, Z. Chen, M. K. Jenkins. 1997. Murine lymphotactin: gene structure, post-translational modification and inhibition of expression by CD28 costimulation. Cytokine 9:375.[Medline]
  35. Yoshida, T., D. Izawa, T. Nakayama, K. Nakahara, M. Kakizaki, T. Imai, R. Suzuki, M. Miyasaka, O. Yoshie. 1999. Molecular cloning of mXCR1, the murine SCM-1/lymphotactin receptor. FEBS Lett. 458:37.[Medline]



This article has been cited by other articles:


Home page
 J. Immunol.Home page
S. B. S. King, A. M. Knorn, C. Ohnmacht, and D. Voehringer
Accumulation of Effector CD4 T Cells during Type 2 Immune Responses Is Negatively Regulated by Stat6
J. Immunol., January 15, 2008; 180(2): 754 - 763.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
A. Biswas, P. Banerjee, and T. Biswas
Priming of CD4+ T cells with porin of Shigella dysenteriae activates the cells toward type 1 polarization
Int. Immunol., January 1, 2008; 20(1): 81 - 88.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Z. Mikhak, C. M. Fleming, B. D. Medoff, S. Y. Thomas, A. M. Tager, G. S. Campanella, and A. D. Luster
STAT1 in Peripheral Tissue Differentially Regulates Homing of Antigen-Specific Th1 and Th2 Cells.
J. Immunol., April 15, 2006; 176(8): 4959 - 4967.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. L. Matsuda, Q. Zhang, R. Ndonye, S. K. Richardson, A. R. Howell, and L. Gapin
T-bet concomitantly controls migration, survival, and effector functions during the development of V{alpha}14i NKT cells
Blood, April 1, 2006; 107(7): 2797 - 2805.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. F. Debes, M. E. Dahl, A. J. Mahiny, K. Bonhagen, D. J. Campbell, K. Siegmund, K. J. Erb, D. B. Lewis, T. Kamradt, and A. Hamann
Chemotactic Responses of IL-4-, IL-10-, and IFN-{gamma}-Producing CD4+ T Cells Depend on Tissue Origin and Microbial Stimulus
J. Immunol., January 1, 2006; 176(1): 557 - 566.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Yang, B. E. Castle, A. Hanidu, L. Stevens, Y. Yu, X. Li, C. Stearns, V. Papov, D. Rajotte, and J. Li
Sphingosine Kinase 1 Is a Negative Regulator of CD4+ Th1 Cells
J. Immunol., November 15, 2005; 175(10): 6580 - 6588.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. S. Duffield, P. G. Tipping, T. Kipari, J.-F. Cailhier, S. Clay, R. Lang, J. V. Bonventre, and J. Hughes
Conditional Ablation of Macrophages Halts Progression of Crescentic Glomerulonephritis
Am. J. Pathol., November 1, 2005; 167(5): 1207 - 1219.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
Y. Morimoto, Y. Bian, P. Gao, Y. Yashiro-Ohtani, X.-Y. Zhou, S. Ono, H. Nakahara, M. Kogo, T. Hamaoka, and H. Fujiwara
Induction of surface CCR4 and its functionality in mouse Th2 cells is regulated differently during Th2 development
J. Leukoc. Biol., September 1, 2005; 78(3): 753 - 761.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
R. Nagarkatti, C. B-Rao, V. Vijayan, S. K. Sharma, and B. Ghosh
Signal Transducer and Activator of Transcription 6 Haplotypes and Asthma in the Indian Population
Am. J. Respir. Cell Mol. Biol., September 1, 2004; 31(3): 317 - 321.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. G. Cronshaw, C. Owen, Z. Brown, and S. G. Ward
Activation of Phosphoinositide 3-Kinases by the CCR4 Ligand Macrophage-Derived Chemokine Is a Dispensable Signal for T Lymphocyte Chemotaxis
J. Immunol., June 15, 2004; 172(12): 7761 - 7770.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
C.-R. Wang, M.-F. Liu, Y.-H. Huang, and H.-C. Chen
Up-regulation of XCR1 expression in rheumatoid joints
Rheumatology, May 1, 2004; 43(5): 569 - 573.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. Muller, S. Bischof, F. Sommer, M. Lohoff, W. Solbach, and T. Laskay
Differential Production of Macrophage Inflammatory Protein 1{gamma} (MIP-1{gamma}), Lymphotactin, and MIP-2 by CD4+ Th Subsets Polarized In Vitro and In Vivo
Infect. Immun., November 1, 2003; 71(11): 6178 - 6183.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Stievano, V. Tosello, N. Marcato, A. Rosato, A. Sebelin, L. Chieco-Bianchi, and A. Amadori
CD8+{alpha}{beta}+ T Cells That Lack Surface CD5 Antigen Expression Are a Major Lymphotactin (XCL1) Source in Peripheral Blood Lymphocytes
J. Immunol., November 1, 2003; 171(9): 4528 - 4538.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H.-C. Chang, S. Zhang, I. Oldham, L. Naeger, T. Hoey, and M. H. Kaplan
STAT4 Requires the N-terminal Domain for Efficient Phosphorylation
J. Biol. Chem., August 22, 2003; 278(34): 32471 - 32477.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
X. Huang and L. D. Hazlett
Analysis of Pseudomonas aeruginosa Corneal Infection Using an Oligonucleotide Microarray
Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3409 - 3416.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Raman, M. H. Kaplan, C. M. Hogaboam, A. Berlin, and N. W. Lukacs
STAT4 Signal Pathways Regulate Inflammation and Airway Physiology Changes in Allergic Airway Inflammation Locally Via Alteration of Chemokines
J. Immunol., April 1, 2003; 170(7): 3859 - 3865.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. L. Williams, A. J. Zullo, M. H. Kaplan, R. R. Brutkiewicz, C. D. Deppmann, C. Vinson, and E. J. Taparowsky
BATF Transgenic Mice Reveal a Role for Activator Protein-1 in NKT Cell Development
J. Immunol., March 1, 2003; 170(5): 2417 - 2426.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. M. Jensen, S. L. Meijer, R. A. Kurt, W. J. Urba, H.-M. Hu, and B. A. Fox
Regression of a Mammary Adenocarcinoma in STAT6-/- Mice Is Dependent on the Presence of STAT6-Reactive T Cells
J. Immunol., February 15, 2003; 170(4): 2014 - 2021.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
M. J. Scott, C. J. Godshall, and W. G. Cheadle
Jaks, STATs, Cytokines, and Sepsis
Clin. Vaccine Immunol., November 1, 2002; 9(6): 1153 - 1159.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Shen and M. H. Kaplan
The Homeostasis But Not the Differentiation of T Cells Is Regulated by p27Kip1
J. Immunol., July 15, 2002; 169(2): 714 - 721.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Vicentini, P. Mazzi, E. Caveggion, S. Continolo, L. Fumagalli, J. A. Lapinet-Vera, C. A. Lowell, and G. Berton
Fgr Deficiency Results in Defective Eosinophil Recruitment to the Lung During Allergic Airway Inflammation
J. Immunol., June 15, 2002; 168(12): 6446 - 6454.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. F. Skinnider and T. W. Mak
The role of cytokines in classical Hodgkin lymphoma
Blood, May 29, 2002; 99(12): 4283 - 4297.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. Blease, J. M. Schuh, C. Jakubzick, N. W. Lukacs, S. L. Kunkel, B. H. Joshi, R. K. Puri, M. H. Kaplan, and C. M. Hogaboam
Stat6-Deficient Mice Develop Airway Hyperresponsiveness and Peribronchial Fibrosis during Chronic Fungal Asthma
Am. J. Pathol., February 1, 2002; 160(2): 481 - 490.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. F. Skinnider, A. J. Elia, R. D. Gascoyne, B. Patterson, L. Trumper, U. Kapp, and T. W. Mak
Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma
Blood, January 15, 2002; 99(2): 618 - 626.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
C. J. Godshall, A. B. Lentsch, J. C. Peyton, M. J. Scott, and W. G. Cheadle
STAT4 Is Required for Antibacterial Defense but Enhances Mortality during Polymicrobial Sepsis
Clin. Vaccine Immunol., November 1, 2001; 8(6): 1044 - 1048.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. K. Park, K. F. Hoffmann, A. W. Cheever, D. Amichay, T. A. Wynn, and J. M. Farber
Patterns of Chemokine Expression in Models of Schistosoma mansoni Inflammation and Infection Reveal Relationships between Type 1 and Type 2 Responses and Chemokines In Vivo
Infect. Immun., November 1, 2001; 69(11): 6755 - 6768.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
A. Mathew, J. A. MacLean, E. DeHaan, A. M. Tager, F. H.Y. Green, and A. D. Luster
Signal Transducer and Activator of Transcription 6 Controls Chemokine Production and T Helper Cell Type 2 Cell Trafficking in Allergic Pulmonary Inflammation
J. Exp. Med., May 7, 2001; 193(9): 1087 - 1096.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
D. Huang, J. Wang, P. Kivisakk, B. J. Rollins, and R. M. Ransohoff
Absence of Monocyte Chemoattractant Protein 1 in Mice Leads to Decreased Local Macrophage Recruitment and Antigen-Specific T Helper Cell Type 1 Immune Response in Experimental Autoimmune Encephalomyelitis
J. Exp. Med., March 19, 2001; 193(6): 713 - 726.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. A. Lawless, S. Zhang, O. N. Ozes, H. A. Bruns, I. Oldham, T. Hoey, M. J. Grusby, and M. H. Kaplan
Stat4 Regulates Multiple Components of IFN-{gamma}-Inducing Signaling Pathways
J. Immunol., December 15, 2000; 165(12): 6803 - 6808.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Zhang, V. A. Lawless, and M. H. Kaplan
Cytokine-Stimulated T Lymphocyte Proliferation Is Regulated by p27Kip1 1
J. Immunol., December 1, 2000; 165(11): 6270 - 6277.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, S.
Right arrow Articles by Kaplan, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, S.
Right arrow Articles by Kaplan, M. H.
Right arrowPubmed/NCBI databases
*Substance via MeSH

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS